ES8301466A1 - Un procedimiento de sintesis de la n(1-alil-2-pirrolidinil- metil)-2-metoxi-4-amino-5-metilsulfamoil-benzamida - Google Patents

Un procedimiento de sintesis de la n(1-alil-2-pirrolidinil- metil)-2-metoxi-4-amino-5-metilsulfamoil-benzamida

Info

Publication number
ES8301466A1
ES8301466A1 ES503805A ES503805A ES8301466A1 ES 8301466 A1 ES8301466 A1 ES 8301466A1 ES 503805 A ES503805 A ES 503805A ES 503805 A ES503805 A ES 503805A ES 8301466 A1 ES8301466 A1 ES 8301466A1
Authority
ES
Spain
Prior art keywords
methyl
pyrrolidinyl
allyl
methoxy
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES503805A
Other languages
English (en)
Other versions
ES503805A0 (es
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of ES503805A0 publication Critical patent/ES503805A0/es
Publication of ES8301466A1 publication Critical patent/ES8301466A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Abstract

PROCEDIMIENTO DE SINTESIS DE LA N(1-ALIL-2-PIRROLIDINIL-METIL)-2- METOXI-4-AMINO-5-METILSULFAMOIL-BENZAMIDA, SUS SALES DE AMONIO CUARTENARIO, SUS N-OXIDOS, Y SUS ISOMEROS OPTICOS, ASI COMO SUS SALES DE ADICION DE ACIDOS FARMACOLOGICAMETE ACEPTABLES. CONSISTE EN HACER REACCIONAR CLOROFORMIATO DE ETILO CON EL ACIDO 2-METOXI-4-AMINO-5-METILSULFAMOIL-BENZOICO, EN PRESENCIA DE TRIETILAMINA, Y EN HACER REACCIONAR DESPUES LA N-ALIL-2-AMINOMETIL-PIRROLIDINA CON EL ANHIDRIDO MIXTO OBTENIDO EN LA REACCION ANTERIOR, CON LO QUE SE OBTIENE LA BENZAMIDA. DE APLICACION EN MEDICINA PARA EL TRATAMIETO DE LA JAQUECA.
ES503805A 1980-08-28 1981-07-09 Un procedimiento de sintesis de la n(1-alil-2-pirrolidinil- metil)-2-metoxi-4-amino-5-metilsulfamoil-benzamida Expired ES8301466A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8018635A FR2489327B1 (fr) 1980-08-28 1980-08-28 N (1 allyl 2 pyrrolidinyl methyl) 2 methoxy 4 amino 5 methylsulfa moyl benzamide, son procede de preparation et son application comme medicament

Publications (2)

Publication Number Publication Date
ES503805A0 ES503805A0 (es) 1982-12-01
ES8301466A1 true ES8301466A1 (es) 1982-12-01

Family

ID=9245444

Family Applications (1)

Application Number Title Priority Date Filing Date
ES503805A Expired ES8301466A1 (es) 1980-08-28 1981-07-09 Un procedimiento de sintesis de la n(1-alil-2-pirrolidinil- metil)-2-metoxi-4-amino-5-metilsulfamoil-benzamida

Country Status (41)

Country Link
US (2) US4405636A (es)
EP (1) EP0047207B1 (es)
JP (1) JPS5775969A (es)
KR (1) KR840002063B1 (es)
AR (1) AR226737A1 (es)
AT (1) ATE11911T1 (es)
AU (1) AU549396B2 (es)
BE (1) BE890085A (es)
BG (1) BG36931A3 (es)
CA (1) CA1168250A (es)
CH (1) CH648299A5 (es)
CS (1) CS223895B2 (es)
DD (1) DD202011A5 (es)
DE (2) DE3133768A1 (es)
DK (1) DK157845C (es)
EG (1) EG15376A (es)
ES (1) ES8301466A1 (es)
FI (1) FI73207C (es)
FR (1) FR2489327B1 (es)
GB (1) GB2083033B (es)
GR (1) GR74560B (es)
HK (1) HK55989A (es)
HU (1) HU183555B (es)
IE (1) IE51357B1 (es)
IL (1) IL63217A (es)
IN (1) IN155495B (es)
IS (1) IS1213B6 (es)
IT (1) IT1171490B (es)
JO (1) JO1120B1 (es)
LU (1) LU83583A1 (es)
MA (1) MA19218A1 (es)
MX (1) MX6707E (es)
NO (1) NO155097C (es)
OA (1) OA06877A (es)
PH (1) PH19211A (es)
PL (1) PL135397B1 (es)
PT (1) PT73509B (es)
SU (1) SU1148559A3 (es)
YU (1) YU42581B (es)
ZA (1) ZA814575B (es)
ZW (1) ZW17581A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8317597D0 (en) * 1983-06-29 1983-08-03 Beecham Group Plc Pharmaceutical compounds
FR2550447B1 (fr) * 1983-08-10 1986-01-17 Ile De France Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire
FR2584605B1 (fr) * 1985-07-15 1988-06-17 Ile De France Application du n-(1-allyl-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide dans le traitement de la maladie de parkinson
US7544676B2 (en) * 2005-11-10 2009-06-09 Adolor Corporation Sulfamoyl benzamides and methods of their use
CN101628886B (zh) * 2009-08-25 2012-12-12 北京紫萌同达科技有限公司 一种2-甲氧基-4-氨基-5-乙砜基苯甲酸的合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1525M (fr) * 1961-07-25 1962-11-16 Ile De France Médicaments antiémétiques nouveaux.
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR5916M (es) * 1966-01-21 1968-05-06
US3766178A (en) * 1967-04-03 1973-10-16 Ile De France Substituted 2-arylalkyloxy benzamides
GB1364231A (en) 1968-12-23 1974-08-21 Robins Co Inc A H N-/1-substituted-3-pyrrolidinyl/benzamides and thiobenzamides
US3862139A (en) * 1972-06-23 1975-01-21 Delmar Chem Heterocyclic benzamide compounds
FR2244760B1 (es) * 1973-09-25 1980-06-27 Ile De France
CH605793A5 (es) * 1974-03-05 1978-10-13 Ile De France
FR2294698A1 (fr) * 1974-12-18 1976-07-16 Synthelabo Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment
US4197243A (en) * 1975-04-02 1980-04-08 Yamanouchi Pharmaceutical Co., Ltd. N-1-Benzyl-3-pyrrolidinyl-4-dimethylamino benzamide derivatives
US4186135A (en) * 1976-08-04 1980-01-29 Societe D'etudes Scientifiques Et Industrielles De L'ile-De-France Substituted 2,3-alkylene bis (oxy) benzamides and derivatives and method of preparation
FR2438650A1 (fr) * 1978-10-11 1980-05-09 Ile De France N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire
US4210660A (en) * 1978-12-20 1980-07-01 Yamanouchi Pharmaceutical Co., Ltd. Benzamide derivatives
JPS55130957A (en) * 1979-03-30 1980-10-11 Kyowa Hakko Kogyo Co Ltd Production of benzamide derivative

Also Published As

Publication number Publication date
PT73509A (fr) 1981-09-01
MA19218A1 (fr) 1982-04-01
US4550179A (en) 1985-10-29
ATE11911T1 (de) 1985-03-15
EP0047207A1 (fr) 1982-03-10
AR226737A1 (es) 1982-08-13
DE3133768A1 (de) 1982-06-16
AU549396B2 (en) 1986-01-23
DK383081A (da) 1982-03-01
EG15376A (en) 1986-12-30
EP0047207B1 (fr) 1985-02-20
DK157845B (da) 1990-02-26
GB2083033B (en) 1984-02-01
CA1168250A (fr) 1984-05-29
US4405636A (en) 1983-09-20
PH19211A (en) 1986-02-04
PT73509B (fr) 1982-10-28
IS2654A7 (is) 1981-09-11
LU83583A1 (fr) 1981-12-01
IE811449L (en) 1982-02-28
ZA814575B (en) 1982-07-28
KR840002063B1 (ko) 1984-11-09
IN155495B (es) 1985-02-09
ES503805A0 (es) 1982-12-01
GR74560B (es) 1984-06-29
PL135397B1 (en) 1985-10-31
JPS5775969A (en) 1982-05-12
JPH0233027B2 (es) 1990-07-25
BG36931A3 (en) 1985-02-15
FI812506L (fi) 1982-03-01
GB2083033A (en) 1982-03-17
DD202011A5 (de) 1983-08-24
FR2489327B1 (fr) 1984-05-18
NO812937L (no) 1982-03-01
DK157845C (da) 1990-07-23
DE3169052D1 (en) 1985-03-28
MX6707E (es) 1985-10-23
OA06877A (fr) 1983-04-30
KR830006201A (ko) 1983-09-20
BE890085A (fr) 1982-02-26
FI73207C (fi) 1987-09-10
NO155097C (no) 1987-02-11
IL63217A (en) 1985-03-31
AU7464281A (en) 1982-03-04
IL63217A0 (en) 1981-10-30
HK55989A (en) 1989-07-21
ZW17581A1 (en) 1981-10-21
CH648299A5 (fr) 1985-03-15
CS223895B2 (en) 1983-11-25
NO155097B (no) 1986-11-03
IT8149179A0 (it) 1981-08-26
IE51357B1 (en) 1986-12-10
IT1171490B (it) 1987-06-10
FR2489327A1 (fr) 1982-03-05
FI73207B (fi) 1987-05-29
YU201081A (en) 1983-10-31
YU42581B (en) 1988-10-31
JO1120B1 (en) 1982-07-10
HU183555B (en) 1984-05-28
IS1213B6 (is) 1986-04-02
PL232686A1 (es) 1982-03-01
SU1148559A3 (ru) 1985-03-30

Similar Documents

Publication Publication Date Title
CS145091A3 (en) Isoxazole-4-carboxamides and amides of hydroxyalkylidene cyanacetic acid, medicaments comprising said compounds and their application
IS1565B (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
ES482097A1 (es) Procedimiento para preparar derivados acilicos de carnitina.
DE3062981D1 (en) Alkyl-urea derivatives for the treatment of lipometabolic diseases; process for their preparation, their use in medicaments for the treatment of lipometabolic disorders, medicaments containing them, process for the preparation of the medicaments, and some alkyl-urea derivatives
ES448588A1 (es) Un procedimiento para la preparacion de un compuesto hetero-arilico.
ES8503643A1 (es) Un procedimiento para la preparacion de compuestos de bis (carboxamida)
EP0000741A3 (en) Indolacetoxy acetylamino acid derivatives, process for their preparation and their use as drugs
ES8301466A1 (es) Un procedimiento de sintesis de la n(1-alil-2-pirrolidinil- metil)-2-metoxi-4-amino-5-metilsulfamoil-benzamida
EP0130109A3 (en) Derivatives of thiophenesulfonamide, their preparation and pharmaceutical composition for the topical treatment of elevated intraocular pressure
SE408412B (sv) Forfarande for framstellning av l-3-(3,4-dihydroxi-fenyl)-2-metyl-alanin-peptider med blodtryckssenkande egenskaper
DK0505400T3 (da) N-substituerede naphthalimider, deres fremstilling og anvendelse
EG12214A (en) Process for preparing of n-(1,2,4-triazin-5-on-4-yl)-glycine derivatives,and their use as herbicides
ES8404693A1 (es) Procedimiento de preparacion de nuevos amino-14 esteroides.
IL48787A0 (en) Pharmaceutical preparations comprising phentolamine,for the treatment of circulatory disorders
ZA814902B (en) Novel thiazol-2-yl-oxamic acid derivatives,their preparation and therapeutic agents containing these compounds
GR80638B (en) Method for the preparation of 2-tolyl-morpholine derivatives and their therapeutical use
ZA7628B (en) Pharmaceutical preparation for the treatment of circulatory disorders
ES2039386T3 (es) Procedimiento para preparar oxolabdanos y su utilizacion para preparar medicamentos.
EG11931A (en) Process for preparing of n-(l'allypyrrolidinyl 2'-methyl)2-methoxy 4,5-azimido benzamide and its derivatives
RO75249A (ro) Procedeu pentru prepararea unor derivati de n-(1,3,4-triadiazol-2-ol)-benzamide
ES8600214A1 (es) Procedimiento para la preparacion de un derivado de n-(4-acetilaminofenacil)-amina
AU4386772A (en) Improvements in or relating to novel compounds for the treatment of excess lipidic and cellulitic stresses, and process for preparing said compounds
DE3469358D1 (en) Novel 3-(4'-aminobutylamino)-propylamino-bleomycin derivatives, a process for their preparation and their use as medicaments
ES466627A1 (es) Procedimiento para la obtencion de derivados amino del 4-hi-droxi-1,2-benzisotiazol
ES8502128A1 (es) Procedimiento para la preparacion de derivados de 6 -metilprednisolona

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971001